AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $37M invested in Akari Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7K

Top Sellers

1
-$1.39M
2
-$714K
3
-$497K
4
QF
QVT Financial
New York
-$442K
5
UBS Group
UBS Group
Switzerland
-$189K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$12.7M
2
$5.84M
3
$5.5M
4
$5M
5
$4.09M
6
$1.89M
7
$1.05M
8
$516K
9
$258K
10
$50K
11
$7K
12
$3K
13
–
14
–
15
–
16
–